APA (7th ed.) Citation

Adams, S., Schmid, P., Rugo, H. S., Winer, E. P., Loirat, D., Awada, A., . . . Cortés, J. (2019). Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study. Annals of oncology, 30(3), 397. https://doi.org/10.1093/annonc/mdy517

Chicago Style (17th ed.) Citation

Adams, S., et al. "Pembrolizumab Monotherapy for Previously Treated Metastatic Triple-negative Breast Cancer: Cohort A of the Phase II KEYNOTE-086 Study." Annals of Oncology 30, no. 3 (2019): 397. https://doi.org/10.1093/annonc/mdy517.

MLA (9th ed.) Citation

Adams, S., et al. "Pembrolizumab Monotherapy for Previously Treated Metastatic Triple-negative Breast Cancer: Cohort A of the Phase II KEYNOTE-086 Study." Annals of Oncology, vol. 30, no. 3, 2019, p. 397, https://doi.org/10.1093/annonc/mdy517.